Three federal agencies are seeking comments on the public’s experience with medical payment products, billing and collection practices in a bid to address possible consumer harms caused by these types of specialty credit products.
The Consumer Financial Protection Bureau (CFPB) has teamed up with the Treasury and the Department of Health and Human Services (HHS) to see whether healthcare providers are promoting financial products — like medical credit cards and loans — to pay for healthcare that raise patient debt and lead to higher consumer costs.
The agencies intend to use the comments to provide a better understanding of the prevalence of these products, patients’ experiences with them and the healthcare providers’ incentives to offer these products to patients.
“Financial firms are partnering with healthcare players to push products that can drive patients deep into debt,” said CFPB Director Rohit Chopra. “We are opening a public inquiry to better understand how these practices are affecting patients in our country.”
In a report on patients with medical debt, first published in May, the agencies found that specialty medical payment products, which were once largely used to pay for care not covered by traditional insurance plans such as dental or vision care, are now being used for more services, including emergency room visits. Some of these services are already covered by insurance or financial assistance plans, but healthcare providers are pitching the higher-cost specialty products to patients instead because they can pass the patient billing and collections over to financial services companies, the CFPB said.
From 2018 to 2020, consumers used specialty medical cards or loans with deferred interest periods to pay for nearly $23 billion in healthcare costs, a recent CFPB study revealed. These newer forms of medical debt are typically more expensive for patients than other forms of payment, including conventional credit cards, with interest rates often exceeding 25%, the study showed.
The agencies are seeking more information on a range of concerns for consumers regarding this market, including interest and fee costs of these products and how they are marketed; whether consumers fully understand the risks of using specialty cards; billing and financial assistance issues; as well as how incentives offered to health care providers affect their promotion of these products to patients.
Esther D’Amico is Kiplinger’s senior news editor. A long-time antitrust and congressional affairs journalist, Esther has covered a range of beats including infrastructure, climate change and the industrial chemicals sector. She previously served as chief correspondent for a financial news service where she chronicled debates in and out of Congress, the Department of Justice, the Federal Trade Commission and the Commerce Department with a particular focus on large mergers and acquisitions. She holds a bachelor’s degree in journalism and in English.
Your American Airlines Flight Just Got More Expensive
American Airlines will now charge more for checked bags on domestic and international flights.
By Jamie Feldman Published
Stock Market Today: Stocks Retreat Ahead of Nvidia Earnings
Stocks fell to start the holiday-shortened week as Nvidia sold off ahead of earnings.
By Karee Venema Published
Biden Has One Last Obamacare Policy To Roll Out: The Kiplinger Letter
The Kiplinger letter This final Obamacare policy would require states to synchronize open enrollment if they operate their own Obamacare exchanges.
By Matthew Housiaux Published
More Weight-Loss Drugs, Like Ozempic, are in the Works: Kiplinger Economic Forecasts
Economic Forecasts Pharmaceutical companies are developing more weight-loss drugs similar to Ozempic, but these injectables are still expensive.
By John Miley Published
Still Have FSA Money to Spend?
Still have FSA money to spend from your healthcare flexible spending account? Here are some ideas to use it up.
By Lisa Gerstner Last updated
Amazon launches RxPass — its new subscription service for medication
Amazon's new program, RxPass, lets Prime members ship prescription medications to their homes for just $5 a month.
By Erin Bendig Published